Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Journal of Nanobiotechnology
|
January 5, 2008
N-hexanoyl chitosan stabilized magnetic nanoparticles: Implication for cellular labeling and magnetic resonance imaging
Shanta R Bhattarai, Remant B Kc, Sun Y Kim, et al.
American Journal of Veterinary Research
|
October 3, 2009
Hoof accelerations and ground reaction forces of Thoroughbred racehorses measured on dirt, synthetic, and turf track surfaces
Jacob J Setterbo, Tanya C Garcia, Ian P Campbell, et al.
The Journal of Molecular Diagnostics : JMD
|
November 4, 2018
Mutation Burden and I Index for Detection of Microsatellite Instability in Colorectal Cancer by Targeted Next-Generation Sequencing
Jeong E Kim, Sung-Min Chun, Yong S Hong, et al.
Veterinary Surgery : VS
|
April 19, 2016
Description and Biomechanical Comparison of a Percutaneous Radiologic Gastropexy Technique in a Canine Cadaver Model
William T N Culp, Ingrid M Balsa, Sun Y Kim, et al.
Iscience
|
November 10, 2021
Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver
Qi Su, Sun Y Kim, Funmi Adewale, et al.
Iscience
|
February 25, 2025
Erratum: Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver
Qi Su, Sun Y Kim, Funmi Adewale, et al.
Metabolism: Clinical and Experimental
|
March 1, 2024
Perturbed liver gene zonation in a mouse model of non-alcoholic steatohepatitis
Ye Zhou, Yuanqi Zhao, Marisa Carbonaro, et al.
Nature
|
April 10, 2015
A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis
Elvin Wagenblast, Mar Soto, Sara Gutiérrez-Ángel, et al.
International Journal of Cancer
|
September 30, 2016
Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial
Francesco Sclafani, Tae Y Kim, David Cunningham, et al.
Journal of the National Cancer Institute
|
September 26, 2015
A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer
Francesco Sclafani, Tae Y Kim, David Cunningham, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Journal of Nanobiotechnology
|
January 5, 2008
N-hexanoyl chitosan stabilized magnetic nanoparticles: Implication for cellular labeling and magnetic resonance imaging
Shanta R Bhattarai, Remant B Kc, Sun Y Kim, et al.
American Journal of Veterinary Research
|
October 3, 2009
Hoof accelerations and ground reaction forces of Thoroughbred racehorses measured on dirt, synthetic, and turf track surfaces
Jacob J Setterbo, Tanya C Garcia, Ian P Campbell, et al.
The Journal of Molecular Diagnostics : JMD
|
November 4, 2018
Mutation Burden and I Index for Detection of Microsatellite Instability in Colorectal Cancer by Targeted Next-Generation Sequencing
Jeong E Kim, Sung-Min Chun, Yong S Hong, et al.
Veterinary Surgery : VS
|
April 19, 2016
Description and Biomechanical Comparison of a Percutaneous Radiologic Gastropexy Technique in a Canine Cadaver Model
William T N Culp, Ingrid M Balsa, Sun Y Kim, et al.
Iscience
|
November 10, 2021
Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver
Qi Su, Sun Y Kim, Funmi Adewale, et al.
Iscience
|
February 25, 2025
Erratum: Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver
Qi Su, Sun Y Kim, Funmi Adewale, et al.
Metabolism: Clinical and Experimental
|
March 1, 2024
Perturbed liver gene zonation in a mouse model of non-alcoholic steatohepatitis
Ye Zhou, Yuanqi Zhao, Marisa Carbonaro, et al.
Nature
|
April 10, 2015
A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis
Elvin Wagenblast, Mar Soto, Sara Gutiérrez-Ángel, et al.
International Journal of Cancer
|
September 30, 2016
Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial
Francesco Sclafani, Tae Y Kim, David Cunningham, et al.
Journal of the National Cancer Institute
|
September 26, 2015
A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer
Francesco Sclafani, Tae Y Kim, David Cunningham, et al.
Page
of 3